Clinical Trials Logo

Gram-negative Infection clinical trials

View clinical trials related to Gram-negative Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05789199 Completed - Clinical trials for Gram-Negative Infection

Use of Cefiderocol in the Management of Gram-Negative Infections

PERSEUS
Start date: July 31, 2022
Phase:
Study type: Observational

The aim of this study is to describe the use of cefiderocol in the management of Gram-negative infections (GNIs) in participants treated through the Early Access Program (EAP) in Spain.

NCT ID: NCT01431326 Completed - Hypertension Clinical Trials

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

PTN_POPS
Start date: November 2011
Phase:
Study type: Observational

Understudied drugs will be administered to children per standard of care as prescribed by their treating caregiver and only biological sample collection during the time of drug administration will be involved. A total of approximately 7000 children aged <21 years who are receiving these drugs for standard of care will be enrolled and will be followed for up a maximum of 90 days. The goal of this study is to characterize the pharmacokinetics of understudied drugs for which specific dosing recommendations and safety data are lacking. The prescribing of drugs to children will not be part of this protocol. Taking advantage of procedures done as part of routine medical care (i.e. blood draws) this study will serve as a tool to better understand drug exposure in children receiving these drugs per standard of care. The data collected through this initiative will also provide valuable pharmacokinetic and dosing information of drugs in different pediatric age groups as well as special pediatric populations (i.e. obese).

NCT ID: NCT00304330 Completed - Clinical trials for Gram Negative Infection

Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients

Start date: September 2006
Phase:
Study type: Observational

The information collected will provide insight in to the epidemiology of antibiotic resistance in a transplant compared to a non-transplant population. Data is needed regarding the date of admission, date of bloodstream infection and location of ward/ICU so trends in the emergence of resistance and antibiotic usage can be detected.